Dietary calcium deficiency and inadequacy elevate blood cholesterol level in hamsters. by Ma, Ka Ying. & Chinese University of Hong Kong Graduate School. Division of Food and Nutritional Sciences.
Dietary Calcium Deficiency and Inadequacy 
Elevate Blood Cholesterol Level in Hamsters 
MA, Ka Ying 
A Thesis Submitted in Partial Fulfillment 
of the Requirement for the Degree of 
Master of Philosophy 
in 
Food and Nutritional Sciences 
I. \ 
i 
©The Chinese University of Hong Kong 
August 2008 
The Chinese University of Hong Kong holds the copyright of this thesis. 
Any person(s) intending to use a part or whole of the materials in the 
thesis in a proposed publication must seek copyright release from the 
Dean of the Graduate School. 
I i 
1 i 
/ y 統 系 餘 f j j y ； ^ 
IIvZl^  ill) 
^ universTty /M/J 
\ 3 ^ i b r a r y smmy-W 
Acknowledgments 
I would like to express my sincere gratitude to my supervisor, Dr. Chen Zhen Yu, 
for his guidance and advice during the entire period of my studies. 
I am also grateful to Ms Yeung Sai Ying Venus and Miss Wong Yin Mei for their 
assistance in Western blotting and intestinal ACAT activity assay. Thanks are due to 
Mr Lam Chuk Kai, Miss Jiao Rui, Miss Tan Si Jiao, Miss Cao Ying and Mr Peng 
Cheng for their help in many experiments. 
I wish to say thank you to my colleagues working in Room 190A, Science 
Centre, and Laboratory Animal Service Center for their help and technical support. 
Finally, I would like to express my deepest thanks to my family and Mr Ng 




Thesis/ Assessment Committee 
Professor LEUNG Lai Kwok (Chair) 
Professor CHEN Zhen Yu (Thesis Supervisor) 
Professor CHUNG Hau Yin (Committee Member) 
i 
Abstract 
Blood total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) 
correlate directly with the risk of heart diseases, whereas high-density lipoprotein 
cholesterol (HDL-C) correlates inversely with the risk. Human observational studies 
have demonstrated a negative correlation between high calcium intake and blood 
cholesterol level in postmenopausal women only. The similar correlation is observed 
between high magnesium intake and blood cholesterol level in humans. However, it 
remains unknown if these studies observe a causal relationship or calcium or 
magnesium intake does affect blood cholesterol level in humans. Therefore, the 
present study was undertaken: a) to study effect of dietary calcium deficiency and 
inadequacy on blood cholesterol profile; b) to investigate the effect of dietary 
magnesium supplementation on blood cholesterol using hamsters as an animal model. 
Effect of calcium on blood cholesterol level was firstly investigated. Golden 
male hamsters (n=33) were randomly divided into three groups. All hamsters were fed 
a calcium adequate diet (8 g/kg diet) containing 0.1% cholesterol for 2 weeks. The 
control group continued to be maintained on the calcium adequate diet, while the two 
tested groups were switched to the diets that contained 2 g calcium /kg or no calcium. 
After the additional 6 weeks, the blood sample was collected and serum was obtained 
II 
after centrifugation. Serum TC, triglycerides (TG), HDL-C and non HDL-C were 
measured. The experiment was repeated in a same way with castrated (n=45), 
ovariectomized (n二36) and female (n=33) hamsters. 
Effect of magnesium on blood cholesterol was also studied. Male hamsters (n=44) 
were divided into four groups. All procedures were similar to previous experiments 
except for the diet. Hamsters were given one of the four diets containing 1.5 g Mg/kg 
diet (high dose), l.Og Mg/kg diet (medium dose), 0.5g Mg/kg diet (adequate dose) 
and 0.05g Mg/kg diet (deficiency dose). 
The results demonstrated that calcium deficiency and inadequacy did not have 
any effect on blood TC, HDL-C and TG levels in male and castrated hamsters. In 
ovariectomized and female hamsters, calcium deficiency increased significantly 
serum TC (p<0.05), non HDL-C (p<0.05) and the ratio of non HDL-C to HDL-C 
(p<0.05) while it decreased significantly HDL-C level (p<0.05). An increasing trend 
in TG was also observed in the calcium deficient ovariectomized hamsters compared 
with the calcium adequate ovariectomized hamsters. In female hamsters, TG (p<0.05) 
was significantly increased in the calcium deficiency group. 
The results showed that magnesium supplementation increased TG (p<0.05) 
significantly in male hamsters. Supplementation of magnesium did not have any 
effect on blood TC, HDL-C, non HDL-C and the ratio of non HDL-C to HDL-C in 
III 
hamsters. 
The present results disapprove the claim that calcium or magnesium 
down-regulates blood cholesterol level, at least, in male or castrated hamsters. 
However, the present study demonstrated a negative correlation between high calcium 
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Calcium is an essential element in the maintenance of body functions and is the 
most abundant mineral in bones and teeth. The small amount of calcium was found in 
plasma with 3 forms: ionized calcium (50%), protein-bound calcium (40%) and 
citrate-and-phosphate-bound soluble calcium (10%) (Molina, 2004). Biological 
functions regulated by intracellular calcium are quite diverse. Body tissues are also a 
regulator of calcium. The gastrointestinal tract and kidney, along with bone, are the 
major regulators of calcium balance (Schulkin, 2001). 
Maintenance of a normal plasma calcium concentration is important in many 
biological functions including blood clotting, proper membrane permeability and 
variety of cell signaling pathways. Calcium acts as a second messenger of hormone 
action, as a signal for neurotransmitter release from axons in response to action 
potentials, and as the response to electrical excitation in muscle contraction (Fox, 
2002). 
1.1.1 Recommendation of calcium intake 
Recommendation of calcium intake is not less than 1,000 mg per day (World 
Health Organization & Food and Agriculture Organization of the United Nations, 
1 
2004). It depends on the age and sex. Calcium is found abundant in dairy products. 
Some vegetarians exclude milk and meat, while some people do not use milk in 
cuisines due to their cultures. They can also obtain calcium from the other food source 
like soybean, broccoli and bok choy. It should be noted that calcium may be poorly 
absorbed from foods rich in oxalic acid or phytic acid, for example, spinach, sweet 
potatoes, seeds and nuts. Chronic calcium deficiency resulting from inadequate intake 
or poor intestinal absorption is one of several important causes of reduced bone mass 
and osteoporosis. 
1.1.2 Calcium toxicity 
Unlike other minerals, there has not been emphasis on the direct toxic effects of 
calcium intakes. With little concern about toxic effects of calcium exists, calcium 
behaves as a threshold nutrient because of its limited absorption at high dietary intake. 
High intakes of calcium, greater than 1,000 mg per day, yield little additional 
absorption of calcium ion beyond a threshold value (Matkovic & Heaney, 1992). 
1.1.3 Calcium homeostasis 
Plasma calcium concentration is regulated by parathyroid hormone (PTH), 
1,25-dihydorxyvitamin D3 (l,25(OH)2D3) and calcitonin (Figure 1.1) with 
involvement of the three principle organs: bone, intestine and kidney. 
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Figure 1.1 Blood calcium is regulated through the hormones: calcitonin and 











1.1.3.1 Role of parathyroid hormone in calcium homeostasis 
PTH secretes from parathyroid glands when the plasma concentration of calcium 
begins to fall, in order to raise the plasma concentration of calcium. To raise the 
calcium concentration, PTH stimulates the activity of osteoclasts to resorb bone, 
hydrolyzing hydroxyapatite (Cai0(PO4)6(OH)2) in bone and returning calcium to the 
blood (Fox, 2002). Also, kidneys are stimulated by PTH to reabsorb calcium ion. 
Moreover, l,25(OH)2D3 are synthesized in response to secretion of PTH. 
1,25(0H)2D3 acts also to raise the blood calcium level. 
1.1.3.2 Role of 1,25-dihydroxyvitamin D3 in calcium homeostasis 
Sunlight radiation can convert precursor molecule 7-dehydrocholesterol into 
vitamin D3 under skin. Vitamin D3 can also be obtained from the diet. In the liver, 
vitamin D3 can be converted into 25-dihydroxyvitamin D3. l,25(OH)2D3 is produced 
from 25-dihydroxyvitamin D3 through hydroxylation in kidney (Figure 1.2). Sun 
exposure is a good source of vitamin D as very few foods naturally contain significant 
amounts of vitamin D. Fish liver oils, milk, soy milk and cereal grains are the fortified 
products to provide vitamin D. 
1,25(0H)2D3 raises the plasma calcium concentration by stimulating the 
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Figure 1.2 Production of l,25(OH)2D3. 7-Dehydrocholesterol under the skin is 
• converted to vitamin D3 by sunlight radiation. Vitamin D3 is converted into 
i 
I 25-dihydroxyvi tamin D3 in the liver. l,25(OH)2D3 is produced from 




1.1.3.3 Role of calcitonin in calcium homeostasis 
Calcitonin is secreted by parafollicular cells (C cell) of the thyroid (Fox, 2002). 
More recently, nonthyroid sources of calcitonin have been identified, including the 
bronchial cells of the lung, prostate and brain. The physiologic role of calcitonin in 
these tissues is still not known (Molina, 2004). 
Calcitonin has the ability to decrease blood calcium level with target on two 
organs: bone and kidney. When plasma calcium level increases, calcitonin is secreted 
and performs an inhibition on the activity of osteoclasts to reduce bone resorption. 
The urinary excretion of calcium is stimulated to lower plasma calcium concentration. 
Calcitonin has been used therapeutically for the prevention of bone loss (Civitelli 
et al, 1988; Stepan et al, 1989). The ability of calcitonin to inhibit osteoclast-mediated 
bone resorption has made as a useful agent for the treatment of osteoporosis. 
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1.2 Magnesium 
Magnesium (1 ounce) is present in the body of a 130-pound person (Whitney & 
Rolfes, 2002). Magnesium distributes in bones, muscles and soft tissues, while only 
1% is present in the extracellular fluid. 
Magnesium is a required cofactor for over 300 enzyme systems (Wacker & Parisi， 
1968). It is required for both anaerobic and aerobic energy generation and for 
glycolysis indirectly as a Mg-ATP complex or directly as an enzyme activator 
(Garfinkel & Garfinkel, 1985). Also, it is partially responsible for the synthesis of 
protein, fat, and nucleic acids and has some role in the cell's membrane transport 
systems. 
1.2.1 Recommendation of magnesium intake 
According to World Health Organization & Food and Agriculture Organization 
of the United Nations, dietary magnesium should be not less than 220mg and 260mg 
per day for adult females and males, respectively. Whole grains, nuts, spinach and 
shellfish are good sources of magnesium. Toxicity is rare, but it can be fatal (McGuire 
et al, 2000). It may occur with high intakes from nonfood sources. The symptoms 
include diarrhea, alkalosis and dehydration (Whitney & Rolfes, 2002). Deficiency 
symptoms include weakness, loss of appetite and impair central nervous system 
activity. 
7 
1.2.2 Absorption and secretion of magnesium 
In humans, magnesium is absorbed mainly in the ileum and jejunum as an ion by 
passive and active uptake mechanisms which seem not to be under the hormonal 
control (Kayne & Lee，1993). High fiber diet reduces magnesium absorption by 
binding to phytate (Brink & Beynen，1992). There are some interactions between 
magnesium and calcium but no significant effect of calcium on magnesium absorption 
was detected (Fine et al, 1991). The kidney excretes most part of the absorbed 
magnesium via urine. The loss is about lOOmg per day (Vormann, 2003). 
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1.3 Cholesterol 
Cholesterol is an important chemical in human body. It is a constituent of most 
animal tissues and cellular membranes. Cholesterol serves as a precursor of bile acids 
and steroid hormones in mammals. Most cholesterol in the human body is found in 
ce l l membranes as a lipid bilayer modulator. A cholesterol molecule contains two 
functional groups, a polar hydroxyl group and a non-polar alkyl group, making it 




Figure 1.3 The structure of cholesterol. 
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1.3.1 Cholesterol homeostasis 
Liver is an organ in the body, which regulates cholesterol metabolism (Dietschy 
et al, 1993). There are three major metabolic pathways in the liver (Arias, 1988). 
Firstly, bile acids are synthesized from cholesterol to maintain the catabolism (Russell 
& Setchell, 1992). Secondly, LDLR takes up the LDL cholesterol in the circulation as 
an exogenous pathway. Thirdly, acetate is used to synthesize cholesterol as an 
endogenous biosynthesis pathway. 
Plasma lipoproteins serve as a transport system for cholesterol. All cells can 
synthesize cholesterol from simple precursors, thus, it is not required in the 
mammalian diet. When cholesterol is in excess, it can be eliminated by biliary 
excretion as bile acids. Liver, which is a centre for producing bile acid, plays an 
important role in cholesterol metabolism. The hepatic cholesterol can regulate the 
level of cholesterol in plasma through the regulatory proteins. They are: 
3 -hydroxy-3 -methylglutaryl-Co A reductase (HMGR), low-density lipoprotein 
receptors (LDLR), cholesterol 7a—hydroxylase (CYP7A1), sterol regulartory 
element-binding protein-2 (SREBP-2) and liver X receptor a (LXRa). 
HMGR is a rate-limiting synthetic enzyme in cholesterol synthesis. LDLR is a 
protein which removes cholesterol contained in LDL particles from the bloodstream. 
CYP7A1 is a rate-limiting enzyme in the bile acid synthesis. SREBP-2, which 
11 
up-regulate cholesterol synthesis, differs from the SREBP-la and Ic, which activate 
fatty acid synthesis (Weber et al, 2004). Liver X receptor a is expressed mainly in the 
liver while Liver X receptor (3 is expressed in most tissues (Willy et al, 1995). LXRa 
controls expression of CYP7AL Intestinal acyl-CoAxholesterol acyltransferase 
(ACAT) is the enzyme required to convert cholesterol to cholesteryl esters as an 
essential step for cholesterol absorption (Weber et al, 2004). Figure 1.4 shows the 
regulate sites of the cholesterol metabolism. 
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Figure 1.4 Figure shows the roles of sterol regulatory element-binding protein 2 
(SREBP-2), low density lipoprotein receptor (LDLR), 3-hydroxy-3-methylglutaryl 
coenzyme A reductase (HMGR), intestinal acyl cholesterol: acyltransferase (ACAT), 
liver-X-receptor (LXRs) and cholesterol-7a-hydroxylase (CYP7A1) in hepatic 
cholesterol metabolism. 
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1.3.1.1 Role of LDLR 
LDLR activity is regulated by the sterol content of the cell. SREBP-2 is attached 
to the nuclear envelope and endoplasmic reticulum (Duncan et al, 1997). This 
fragment enters the nucleus where it binds and activates transcription of the LDLR 
gene. 
LDL can be removed from the plasma by receptor-dependent and 
receptor-independent mechanisms. The receptor-independent mechanism is not 
influenced by diet (Daniel & Zempleni, 2003). LDLR is highly sensitive to changes in 
dietary cholesterol. LDLR is primarily expressed in the liver and adrenal gland (Kim 
et al, 1996). Liver uses the LDLR, which consists of 839 amino acids, to supply 
cholesterol for excretion into bile for production of bile acids and for synthesis of 
lipoproteins (Goldstein & Brown，1984). LDLR recognizes apolipoprotein B-lOO 
(ApoB-100) which is located on the surface of LDL particles (Brown & Goldstein, 
1974). LDL particles bind to LDLR by forming the complex and enter the cell 
through endocytosis (Goldstein et al, 1977; Anderson et al, 1977). Figure 1.5 shows 
the endosome fuses with a lysosome that contains enzymes to hydrolyze the 
cholesteryl esters, releasing cholesterol and fatty acid into the cytosol. LDLR is then 
back to the cell surface again (Nelson & Cox, 2000). 
Ingestion of cholesterol rich diet can exceed the ability of down-regulated LDLR 
14 
to clear LDL from plasma, resulting in increased plasma LDL concentrations 
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Figure 1.5 The cellular uptake of LDL particles circulating in the blood (1) starts 
with their mooring to LDL-receptors in coated pits (2) on the cell surface. These pits 
invaginate and pinch off to form coated vesicles (3). Fusion of vesicles gives rise to 
an endosome (4) in which the LDL dissociates from the receptor, which is recycled (5) 
to the surface. The LDL is delivered to a lysosome where the cholesteryl ester is 
cleaved to yield free cholesterol to be utilized for membrane synthesis or is converted 
to steroid hormones and bile acids. Cholesterol taken up by the cell inhibits the cell's 
own cholesterol synthesis (Brown & Goldstein, 1984). 
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1.3.1.2 Role of SREBP-2 
SREBPs have three isoforms, they are SREBP-la, SREBP-lc and SREBP-2 
(Weber et al, 2004). A hairpin domain consists of two membrane-spanning domains 
separated by a short 31-amino-aicd loop facing the lumen of the endoplasmic 
reticulum and nuclear envelope (Hua et ai, 1993). The N-terminal domain of SREBPs 
contains a basic helix-loop-helix leucine zipper (bHLH-ZIP) motif which provides a 
DNA-binding domain while C-terminal domain faces the cytosol. When SREBPs are 
activated the N-terminal domain translocate to the nucleus and activates the 
transcription of sterol-responsive genes involved in cholesterol and fatty acid 
metabolism (Brown & Goldstein, 1999). In response to signals, two sequential 
proteolytic cleavages are required at site-1 and site-2 by site-1 protease (SIP) and 
site-2 protease (S2P) respectively. N-terminal domain of SREBPs releases from the 
ER membrane and translocates to the nucleus (Sakai et al, 1996). 
The transcription of sterol-responsive genes such LDLR and HMGR are 
activated by the binding of SREBP-2 to a sterol regulatory element (SRE) (Horton et 
al, 1998). Figure 1.6 is illustrated the proteolytic cleavages of SREBPs and the 
translocation of mature SREBPs into the nucleus. 
17 
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Figure 1.6 Maturation of SREBPs and their transactivation function. Proteolytic 
cleavages at site-1 and 2 release domain of SREBPs from the ER to nucleus. Binding 
of the mature SREBP to a SRE activates the transcription of sterol-responsive genes. 
SREBP cleavage-activating protein (SCAP) functions as a sterol sensor for the 
cleavage of site-1 (Brown & Goldstein, 1999). 
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1.3.1.3 HMGR as rate limiting step for cholesterol synthesis 
HMGR is found in the endoplasmic reticulum of the liver and other cells. HMGR 
involves in classic cholesterol synthetic pathway as a rate-determining step (Figure 
1.7). Increased intake, absorption and transport of cholesterol to cells decreases 
HMGR activity through SREBP-mediated regulation of gene expression (Daniel & 
Zempleni, 2003). In contrast, when cholesterol is depleted in cell, mature SREBPs are 
transported to the nucleus, binding the promoter regions of HMGR, and so, increasing 
HMGR transcription. Drugs inhibit HMGR like statins, lovastatin are used to lower 
serum cholesterol as a means of reducing the risk for cardiovascular disease. 
19 
Acetyl-CoA + Acetoacetyl-CoA 









Figure 1.7 Cholesterol formation starts with acetyl-CoA. HMGR controls the 
synthesis of HMG-CoA that also controls the synthesis of cholesterol. 
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1.3.1.4 CYP7A1 as a key factor in production of bile acids 
Hepatic cholesterol pool is maintained largely by an increased conversion of 
cholesterol to bile acids or secretion of free cholesterol into bile in response to the 
increased dietary cholesterol and fat intake. 
Approximately 95% of bile acids are reabsorbed in the small intestine via passive 
or active transport mechanisms and back to the liver. This circulation plays an 
important role in lipid absorption, bile acid synthesis and cholesterol homeostasis 
(Daniel & Zempleni, 2003). Bile helps to emulsify fats and enhances the absorption of 
fat and fat-soluble vitamin A, D, E and K in the small intestine. 
There are two distinct pathways for bile acid synthesis: the classical (neutral) and 
the alternative (acidic) pathway. The classic or neutral pathway, common to all 
mammals, is initiated by cholesterol 7a—hydroxylase (CYP7A1) (Schwarz et al, 2001). 
This enzyme is located in the endoplasmic reticulum and catalyzes the rate-limiting 
step in the neutral pathway (Russell, 2003). The mitochondrial sterol 27-hydroxylase 
is suggested to be the limiting enzyme in alternative bile acid synthesis (Daniel & 
Zempleni, 2003). CYP7A1 is responsible for the 7a hydroxylation of cholesterol into 
7a-hydroxycholesterol, the first and rate-limiting step in bile acid synthesis (Norlin & 
Wikvall, 2007). 
Dietary cholesterol increases mRNA and activity of CYP7A1 as a compensatory 
21 
response to maintain cholesterol homeostasis in rats (Pandak et al, 1991). Changing 
the activity of CYP7A1 would cause the change of the blood cholesterol (Hubacek & 
Bobkova, 2006). 
1.3.1.5 Role of LXR in production of bile acids 
Two LXRs have been identified in mammals. LXRs were first identified as 
orphan nuclear receptors. LXRa and LXR(3 have specificity similar to oxysterol 
ligands and activated by naturally occurring oxysterols which are oxidized derivatives 
of cholesterol. LXR(3 could not compensate for the absence of LXRa with regard to 
bile acid synthesis and secretion in the LXRa knockout mice (Peet et al, 1998). Also, 
LXRa knocked out mice failed to increase transcription of CYP7A1 and consequently 
showed a marked increase in hepatic cholesteryl ester concentrations. It shows LXRs 
involvement in cholesterol metabolism. To activate LXRa, heterodimerization occur 
with the retinoid X receptors (RXRs). After the activation, LXRa binds to the LXR 
response element (LXRE), as function as transcription factors, in the promoter region 
of the CYP7A1 (Lehmann et al, 1997). 
1.3.1.6 ACAT regulates cholesterol uptake in intestine 
Acyl-CoA:cholesterol acyltransferase (ACAT) is an intracellular enzyme that 
catalyzes the transfer of a long chain fatty acyl residue from acyl-CoA to the 
(3-hydroxyl group of cholesterol to form a cholesteryl ester (Myant, 1990) as shown in 
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Figure 1.8. Two ACAT genes, designated as ACAT-1 and ACAT-2, have been 
identified in mammals (Chang et al, 2000). ACAT-1 has been found in macrophages 
of hepatic cells, adrenal glands, neurons and intestinal cells, while ACAT-2 is 
expressed in the intestinal mucosa and the liver (Burnett et al, 2005; Chang et al, 
2000; Sakashita et al, 2003). In intestinal cholesterol absorption, ACAT-2 is an 
important factor (Parini et al, 2004; Repa et al, 2004). ACAT-2 deficient mice had 
been reported to cause reduced intestinal cholesterol absorption (Buhman et al, 2000; 
Miyazaki et al, 2003; Repa et al, 2004; Willner et al, 2003). 
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Figure 1.8 ACAT and cholesterol ester synthesis. Acyl CoAxholesterol 
acyltransferase (ACAT) catalyzes the covalent joining of cholesterol and long-chain 
fatty acyl-CoA to form cholesterol esters (Chen, 2001). 
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Chapter 2 
Effect of Calcium Deficiency and Inadequacy on 
Blood Cholesterol Level in Intact Male and 
Castrated Hamsters 
2.1 Introduction 
Some experimental and epidemiologic data claim that calcium intake may play a 
role in regulation of body weight and serum profile in humans (Parikh & Yanovski, 
2003). A study was carried out with young subjects (n = 11 male, age 21 to 26) who 
received a diet with either high or low calcium contents in which the fat content was 
either saturated or polyunsaturated. The result showed TC was significantly lower 
(p<0.05) in the group taking a high calcium diet with saturated fat compared with 
those who were taking a low calcium diet. There was no significantly changed in fecal 
excretion in the group with addition of calcium to the saturated fat diet 
(Bhattacharyya et al, 1969). 
In another study, subjects (n : 235 male, 235 female) were divided into 3 groups 
on the basis of their daily calcium intake: lower, medium and high. The result shows 
TC:HDL-C ratio was significantly decreased by 11.30% (p<0.05) in women received 
a high daily calcium intake compared with those who had the low calcium intake 
(Jacqmain et al, 2003). 
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Effect of dietary calcium on excretion of bile acids was conducted in subjects (15 
male, 16 women) received pentacalcium hydroxy-triphosphate supplementation. The 
total bile acid excretion was significantly increased by 11% (p<0.003) during the 
experiment period compared with the placebo period (Ditscheid et al, 2005). 
Calcium has been recognized as a binding agent to lipids in the gut. Thus, 
calcium causes malabsorption of bile acids which is likely to contribute further to 
malabsorption of fat (Reid, 2004). If too much calcium, as calcium ions, is bound to 
oxalates or other anions that precipitate calcium in the gut, then much of the calcium 
will not be bioavailable (Anderson & Gamer, 1996). The highest bioavailability of 
calcium supplement is calcium citrate malate, calcium citrate and calcium lactate. If 
calcium phosphate is used as supplement, insoluble amorphous calcium phosphate 
(ACP) is regenerated in small intestine as the pH no longer acidic in the stomach 
environment. ACP is supposed to bind bile acids, leading bile acid deprivation in the 
liver. Therefore, more cholesterol has to be used for bile acid synthesis, leading to a 
decrease in serum cholesterol (Ditscheid et al, 2005). 
Some data have suggested lipolysis effect in the transgenic mice, which express 
the agouti gene, has been induced by a high dietary calcium intake as a result of 
significantly reduced (p<0.001) weight gain and fat pad mass (Zemel et al, 2000). 
Parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (l,25(OH)2vitD3) have 
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been shown to stimulate a significant and sustained increase in intracellular calcium 
concentration in primary cultures of human adipocytes. Thus, lipogenesis in adiposity 
would be induced. If the dietary calcium intake is increased, the PTH and 
l,25(OH)2vitD3 concentration would be kept low, so was the intracellular calcium and 
the lipid content in adipocytes (Parikh & Yanovski, 2003). 
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2.2 Objective 
Some human observational studies have demonstrated a negative correlation 
between high calcium intake and blood cholesterol level. However, it remains 
unknown if these studies observe a causal relationship or calcium intake does affect 
blood cholesterol level. The objective of the study was therefore undertaken to study 
effect of dietary calcium supplementation in diet on blood cholesterol profile in intact 
male and castrated hamsters. 
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2.3 Materials and methods 
2.3.1 Hamsters 
2.3.1.1 Intact male hamster 
Thirty-three (110 - 115 g, age = 2 months) male Syrian golden hamsters 
{Mesocricetus auratus), were obtained from the Laboratory Animal Services Centre, 
The Chinese University of Hong Kong, and randomly divided into three groups 
(n=l 1/group) and housed in wire-bottom cages at 23°C with a 12-h light-dark cycle in 
the animal room. 
All the hamsters were stabilized by being fed a 0.1% cholesterol and calcium 
adequate diet (8g/kg diet) for 2 weeks. All Frozen diets were given to hamsters daily, 
and uneaten portion was discarded. From week 0 to week 6, the control group 
continued to be maintained on the calcium adequate diet, the other two groups 
received the diet similar to the control group except that they were given 2g of 
calcium per kg of diet (Ca 2g/kg) and no calcium diet (Def). The hamsters were 
allowed freely to access the food and tap water ad libitum. Food intake was measured 
daily and body weight was recorded weekly. The total fecal output of each hamster 
was manually separated from other bedding materials and was pooled in each week 
throughout the experiment. 
Blood was collected from the retro-orbital sinus into a heparinized capillary tube 
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at the end of weeks 0, 3 and 6 after overnight food deprivation. The blood was 
centrifuged at 1500g for 10 minutes and the plasma was collected and stored at -20 
until analysis. 
At the end of 7 weeks, all hamsters were killed after overnight food deprivation. 
The blood was collected via the abdominal aorta. After clothing, the blood was 
centrifuged at 1500g for 10 min, and serum was then collected from the supernatant. 
The liver, heart, kidney and adipose tissue (perirenal and epididymal pads) were 
removed, washed with ice-cold saline, weighed and stored at -80°C until analysis. The 
protocol was reviewed and approved by the Experimental Animal Ethics Committee, 
The Chinese University of Hong Kong. 
2.3.1.2 Castrated hamster 
Similarly, forty-five male hamsters (n二 15/group) were castrated. After a period 
of seven-day recovery, the castrated hamsters were stabilized on a 0.1% cholesterol 
and calcium adequate diet (8g/kg diet). Castrated hamsters were divided into three 
groups similarly as previously described in section 2.3.1.1. From week 0 to week 6, 
all frozen diets were given to hamsters daily, and uneaten portion was discarded. 
Blood collection and other experimental procedures were performed similarly as 
previously described in section 2.3.1.1. 
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2.3.2 Diets 
The ingredients were purchased from Harlan Teklad (Madison, WI, USA) except 
for lard, which was obtained from the local market. DL-methionine, cholesterol and 
calcium phosphate dibasic were purchased from Sigma Chemical (St. Louis, MO, 
US A). The calcium deficient diet was prepared by mixing the following ingredients in 
proportion (g/kg diet): cornstarch, 508; casein, 242; lard, 50; sucrose, 119; calcium 
deficiency mineral mix AIN-76, 40; vitamin mix AIN-76A, 20; DL-methionine, 1; 
cholesterol, 1. The other two experimental diets were prepared by adding 5g CaHPCU 
(2g Ca/kg) and 20g CaHPCU (8g Ca/kg) into the deficient diet, respectively. The 
powdered diets were then mixed with gelatin solution (20g/L) (Table 2.1). Once the 
gelatin had set, the food was cut into 15g cubed portions and stored in a freezer at 
-20°C. 
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Table 2.1 The composition of three diets, calcium deficient (Ca Def), 2g Ca/kg (Ca 
2g/kg) and 8g Ca/kg (Ca 8g/kg). 
Ingredient Ca 8g/kg Ca 2g/kg Ca Def 
Cornstarch 508 508 508 
Casein 242 242 242 
Sucrose 119 119 119 
Lard 50 50 50 
Calcium Deficiency 
40 40 40 
mineral mix (AIN-76) 
Vitamin mix (AIN-76A) 20 20 20 
Gelatin 20 20 20 
DL- Methionine 1 1 1 
Cholesterol 1 1 1 
CaHP04 20 5 0 
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2.3.3 Determination of calcium content in animal diet 
The procedure is the AOAC official method 968.08 (AOAC international, 1995). 
Approximately 2.0g of powered sample was weighed into a porcelain crucible and 
placed into a cold furnace. The temperature was increased to 550�C, and kept at 550°C 
for 4 hours. The carbon-free ash residue was cool to room temperature and dissolved 
with 3M HCl (10ml) and boiled gently 10 minutes. The solution was cool and diluted 
to 100ml. The measurement solutions were prepared from this stock solution by 
two-fold dilution and contained 1% of lanthanum oxide (AAS grade, Sigma, USA) to 
reduce phosphate interference and undergo for analysis. Standard solutions of calcium 
(Sigma) were subjected to the same procedure. The solution was measured in an 
atomic absorption spectrophotometer VARIAN SPECTRAA-800. Instrumental 
conditions were: pump flow rate, 3.0 ml/min; wavelength, 422.7nm; lamp current, 
10mA; slit width, 0.5nm; and air/CsH: flow ratio, 3 to 1. 
2.3.4 Determination of serum lipid, lipoproteins and calcium concentration 
Serum TC and TG were measured using commercial enzymatic kits from Infinity 
(Waltham, MA, USA) and Stanbio Laboratories (Boeme, TX, USA), respectively. The 
concentration of HDL-C was measured after precipitation of LDL and VLDL with 
phosphotungstic acid and magnesium chloride, using a commercial kit (Sigma). 
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Non-HDL cholesterol was calculated as the difference between TC and HDL-C. 
Calcium concentration was measured using commercial kits (Sigma). 
2.3.5 Determination of cholesterol concentration in organs 
Total lipids were extracted from lOOg of organ sample with the addition of 1.5 
mg of stigmastanol (Sigma, St Louis, MO, USA) as an internal standard using 15 mL 
chloroform-methanol (2:1, v/v) and 3 mL saline. The chloroform-methanol phase was 
removed and dried down under a gentle stream of nitrogen gas. The lipid extracts 
were saponified in 6 ml of IN NaOH in 90% ethanol at 90°C for 1 hour. Water was 
added and the cholesterol was extracted by cyclohexane. The cyclohexane phase was 
evaporated to dryness under nitrogen gas. Cholesterol was converted to their 
trimethylsilyl (TMS)-ether derivatives by a commercial TMS-reagent (dry 
pyridine-hexamethyldisilazane- trichlorosilane, 9: 3: 1, v/v/v，Sil-A regent, Sigma). 
After 1 hour at 60°C, the mixture was evaporated under nitrogen gas. The TMS-ether 
derivative was dissolved in 600 mL of hexane. After centrifugation, the hexane phase 
was transferred into a GC vial for gas-liquid chromatograph (GLC) analysis. The 
analysis of cholesterol TMS-ether derivative was performed in a fused silica capillary 
column (SAC TM-5, 30m x 0.25 mm, i.d.; Supelco, Inc., Bellefonte, PA, USA) using 
a Shimadzu GC-14 B GLC equipped with a flame ionization detector (Shimadzu, 
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Kyoto, Japan). The column temperature was set at 285°C and maintained for 20 
minutes. Helium was used as a carrier gas at a head pressure of 22 psi. A typical GLC 
chromatogram of liver cholesterol is shown in Figure 2.1. 
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Figure 2.1 Gas liquid chromatogram profile of cholesterol in the liver. 
Identification of the peaks: 1, cholesterol; 2, stigmastanol (internal standard). 
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2.3.6 Determination of fecal neutral and acidic sterols 
Neutral and acidic sterols in the feces were determined by a method described by 
Czubayko et al (1991) with slight modification. The feces collected were dried in a 
lyophilizer, weighed and ground into powder. Stigmasterol (0.5 mg) in 1 mL of 
chloroform was added as an internal standard for neutral sterols in a methylation tube, 
and was dried down under nitrogen gas. About 300 mg of fecal sample was then 
weighed into the same tube together with 0.5 mg hyodeoxycholic acid (Sigma) in 200 
mL IN NaOH in 90% EtOH. The samples were then hydrolyzed in 8 mL IN NaOH in 
90% EtOH at 90°C for 1 hour. The total neutral sterols were extracted using 8 ml of 
cyclohexane and were then converted to their corresponding TMS-ether derivatives 
for GLC analysis. The remaining aqueous phase was saved for the acidic sterol 
analysis. 
2.3.7 Determination of fecal neutral sterols 
The TMS-ether derivatives of neutral sterols were dissolved in 400|LIL of hexane 
and transferred into a GC vial and analyzed on a fused silica capillary column 
(SAC™-5, 30 m X 0.25 mm internal diameter, Supelco, Bellefonte, PA, USA) in a 
Shimadzu GC-14B GC equipped with a flame-ionization detector (Shimadzu, Kyoto, 
Japan). Helium was used as the carrier gas at head pressure of 22 psi and the column 
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Figure 2.2 Gas liquid chromatogram of fecal neutral sterol analysis. Identification 
of peaks: 1, coprostanol; 2, coprostanone; 3, cholesterol; 4, dihydrocholesterol; 5， 
stigmasterol (internal standard). 
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2.3.8 Determination of fecal acidic sterols 
One mL of ION NaOH was added to the remaining lower aqueous phrase and 
heated at 120°C for 3 hours. After a cooling down period of 30 minutes, 1 mL of 
distilled water and 3 mL of 25% HCl were added followed by extraction with 7 ml of 
diethyl ether twice. The diethyl ether layers were then pooled followed by adding 2 
mL of methanol, 2 mL of dimethoxypropane and 40 jiL of concentrated HCl (37%). 
After standing overnight at room temperature, the solvents were dried down and the 
acidic sterols were similarly converted to their TMS-ether derivatives at 60°C for 
GLC analysis. 
The TMS-ether derivatives were dissolved in 300 |iL of hexane, transferred into 
a GC vial and analyzed on a fused silica capillary column (SAC™-5, 30 m x 0.25 mm 
internal diameter, Supelco, Bellefonte, PA, USA) in a Shimadzu GC-14B GC 
equipped with a flame-ionization detector (Shimadzu, Kyoto, Japan). Helium was 
used as the carrier gas at head pressure of 22 psi and the column temperature was 
programmed from 230�C to 280�C at a rate of 1°C/ min. A typical chromatogram is 




• 丨 • 1 
I 3 
2000�I 6 
. . 彳 I 1 I • 
1500 ^ • 
1 I . 4 
i l l 






1 广一…>..〜.〜 ，…，….、,.、..-《.厂v . . . .一 — . . . . ” . „ J . , 广 , , 
10 20 30 40 50 60 
min 
Figure 2.3 Gas liquid chromatogram of fecal acidic sterol analysis. Identification of 
peaks: 1, lithocholic acid; 2, deoxycholic acid; 3，chenodeoxycholic acid; 4, cholic 
acid; 5, hyodeoxycholic acid (internal standard); 6, ursodexoycholic acid. 
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2.3.9 Statistics 
Results were presented as means 士 standard deviation (S.D.). The analysis of 
variance (ANOVA) followed by student's t-test (two-tailed) was used where 
applicable for statistical evaluation. Differences between groups were considered 
significant when p<0.05. 
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2.4 Results on intact male hamsters 
2.4.1 Diet composition 
The analysis result on calcium content in experimental diet was shown on the 
Figure 2.4. The Ca 8g/kg diet contained 7.64 g 士 0.40g of calcium in 1 kg of diet, Ca 
2g/kg diet contained 1.46g 士 0.27g of calcium per kg of diet and Ca Def diet 
contained 0.43g 士 0.01 g of calcium per kg of diet.. 
2.4.2 Growth and food intake 
The body weight and food intake are shown in Table 2.2. No significant 
differences were observed among the deficient, Ca 2g/kg and Ca 8g/kg groups. 
2.4.3 Organ weights 
The weights of liver, kidney, heart and adipose tissue are shown in Table 2.3. 
There were no significant differences in organs weights among the three groups. 
2.4.4 Effect of calcium deficiency diet on the plasma lipid profile and calcium 
concentration of hamsters 
Plasma TC, HDL-C, nHDL-C and TG in hamsters fed a calcium deficient diet 
were not significantly different from those of the Ca 2g/kg and Ca 8g/kg groups 
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(Table 2.4). Plasma calcium concentration in hamsters were significantly different 
among all three groups (p<0.01) (Table 2.4). 
2.4.5 Effect of calcium deficiency diet on hepatic cholesterol of hamsters 
No significant difference in hepatic cholesterol was observed among the calcium 
deficient, Ca 2g/kg and Ca 8g/kg groups (Table 2.4). 
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Figure 2.4 Analysis of the calcium content in the calcium deficient (Ca Def), 2g 
calcium/kg (Ca 2g/kg) and 8g calcium/kg (Ca 8g/kg) diets that fed the hamsters in the 
study. 
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Table 2.2 Body weight gain and food intake of three groups of hamsters fed the 
calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g calcium/kg (Ca 8g/kg) 
diets. 
Ca 8g/kg Ca 2g/kg Ca Def 
Initial body weight (g) 115.50 土 6.11 114.10 土 5.39 112.70 土 7.20 
Final body weight (g) 127.00 ±13.58 128.20 ± 13.47 125.00 ±8.37 
Food intake (g/day) 10.68±1.24 10.75±1.17 10.53±1.04 
Values are expressed as mean 士 S.D. (n=l 1). 
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Table 2.3 Weights of liver, heart, kidney and adipose tissue of three groups of 
hamsters fed the calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g 
calcium/kg (Ca 8g/kg) diets. 
Ca 8g/kg Ca 2g/kg Ca Def 
Liver (g) 5.04 ± 0.84 5.02 土 0.72 4.82 土 0.40 
Heart (g) 0.49 土 0.05 0.48 土 0.05 0.50 土 0.05 
Kidney (g) 1.28 土 0.30 1.31 土 0.26 1.27 ± 0.11 
Adipose 
1.60 ± 0.35 1.74 ±0.45 1.60 ±0.37 
Tissue (g) 
Values are expressed as mean 士 S.D. (n=l 1). 
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Table 2.4 Effects of feeding the calcium deficiency diet (Ca Def), 2g calcium/kg 
(Ca 2g/kg) and 8g calcium/kg (Ca 8g/kg) diets on the plasma total cholesterol (TC), 
high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (nHDL-C), the 
ratio of nHDL-C to HDL-C, triglycerides (TG), calcium concentration and hepatic 
cholesterol in the hamsters at week 6. 
Ca 8g/kg Ca 2g/kg Ca Def 
TC (mg/dL) 1 7 9 . 0 0 土 2 5 . 8 8 1 7 8 . 9 4 土 1 7 . 8 4 1 6 4 . 1 1 土 2 3 . 8 9 
HDL-C (mg/dL) 52.87 ± 11.60 52.07 ± 13.79 49.07 ± 8.29 
Non HDL-C (mg/dL) 1 2 0 . 9 8 ±21.43 1 3 1 . 8 8 土 18.98 119.64 ± 2 4 . 5 2 
Non HDL-C/HDL-C 2.38 土 0.65 2.64 土 0.75 2.48 土 0.81 
TC/HDL-C 3.50 ±0.82 3.64 ± 0.75 3.19 ±1.40 
Triglyceride (mg/dL) 1 1 9 . 0 8 土 3 3 . 4 8 1 0 0 . 6 2 土 2 7 . 4 3 1 0 8 . 6 0 土 2 4 . 2 0 
Calcium 
concentration 13.37±0.88' 12.28±0.94'^ 9.56±0.77' 
(mg/dL) 
Liver Cholesterol 
38.91 ± 11.70 38.75 ±11.42 46.82 ± 7.92 
(mg/g) 
Values are expressed as mean 士 S.D. (n二 11). Means at the same row differ 
significantly at p<0.01 (a, b, c). 
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2.4.6 Effect of calcium on fecal neutral sterol output 
Concentration of neutral sterols in the feces of the hamsters at week 6 is shown 
in Table 2.5. There was no significant difference in total neutral sterol content in the 
feces of hamsters fed the Ca Def, Ca 2g/kg and Ca 8g/kg diets. 
2.4.7 Effect of calcium on fecal acidic sterol output 
Concentration of fecal acidic sterol output is shown in Table 2.5. There was no 
significant difference in acidic sterol concentration in hamsters fed the three diets. 
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Table 2.5 Effects of three diets on fecal neutral and acidic sterol output in the 
hamsters 
Ca 8g/kg Ca 2g/kg Ca Def 
Neutral Sterol (mg) 3.26 ± 1.39 4.17 ± 2.38 3.57 ± 0.84 
Acidic Sterol (mg) 2.11 ± 0.97 3.50 ± 1.60 2.43 ± 0.80 
Cholesterol intake (mg) 11.83 土 2.76 12.14 ±0.29 12.50 ±0.51 
Cholesterol retained (mg) 6.88 士 2.27 6.26 土 0.54 6.74 士 1.03 
Cholesterol 
56.48 ± 13.89 51.65 ±5.06 54.04±9.14 
retained/cholesterol intake (%) 
Values are expressed as mean 士 S.D. (n=ll). 
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2.5 Results on castrated hamsters 
2.5.1 Growth and food intake 
The body weight and food intake are shown in Table 2.6. There were no 
significant differences in the initial body weight, final body weight and food intake 
among the Ca Def, Ca 2g/kg and Ca 8g/kg groups. 
2.5.2 Organ weights 
The weights of liver, kidney, heart and adipose tissue are shown in Table 2.7. 
There were no significant differences in organ weights among the three groups. 
2.5.3 Effect of calcium deficiency diet on the plasma lipid profile and calcium 
concentration of hamsters 
Plasma TC, HDL-C, nHDL-C and TG in hamsters fed the calcium deficient diet 
was not significantly different from those of Ca 2g/kg and Ca 8g/kg groups (Table 
2.8). Plasma calcium concentration in hamsters were significantly different among all 
three groups (p<0.01) (Table 2.8). 
2.5.4 Hepatic cholesterol 
There is no significant difference of the hepatic cholesterol among the three 
groups (Table 2.8). 
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Table 2.6 Body weight gain and food intake of three groups of hamsters fed the 
calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g calcium/kg (Ca 8g/kg) 
diets. 
Ca 8g/kg Ca 2g/kg Ca Def 
Initial body weight (g) 130.00 土 10.00 128.00 土 10.82 128.00 土 8.41 
Final body weight (g) 137.87 土 16.43 134.93 土 12.74 130.33 土 4.56 
Food intake (g/day) 10.55±1.65 10.37±1.39 9.82±1.39 
Values are expressed as mean 士 S.D. (n=15). 
Table 2.7 Weights of liver, heart, kidney and adipose tissue of three groups of 
hamsters fed the calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g 
calcium/kg (Ca 8g/kg) diets. 
Ca 8g/kg Ca 2g/kg Ca Def 
Liver (g) 6.75 土 1.08 6.57 土 0.79 5.85 土 1.52 
Heart (g) 0.47 ±0.11 0.47 ± 0.09 0.48 ± 0.05 
Kidney (g) 1.26±0.17 1.11 ±0.29 1.06±0.25 
Adipose Tissue (g) 1.37 ±0.31 1.29 ±0.38 1.15 ±0.25 
Values are expressed as mean 土 S.D. (n=15). 
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Table 2.8 Effects of feeding the calcium deficiency diet (Ca Def), 2g calcium/kg 
(Ca 2g/kg) and 8g calcium/kg (Ca 8g/kg) diets on the plasma total cholesterol (TC), 
high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (nHDL-C), the 
ratio of nHDL-C to HDL-C, triglycerides (TG), calcium concentration and hepatic 
cholesterol in the hamsters at week 6 
Ca 8g/kg Ca 2g/kg Ca Def 
TC (mg/dL) 199.45 ± 17.40 188.55 ± 18.04 197.15 ±43.38 
HDL-C (mg/dL) 1 2 0 . 8 4 ± 18.84 116.03 土 14.55 113.12 土 16.59 
Non HDL-C (mg/dL) 76.22 土 16.99 72.51 土 17.21 73.02 土 19.80 
Non HDL-C/HDL-C 0.62 ±0.19 0.61 ± 0.16 0.66 ± 0.21 
TC/HDL-C 1.62 ±0.19 1.61 ±0.16 1.66 ±0.21 
Triglyceride (mg/dL) 118.21 土 25.49 115.74 土 35.11 111.18 土 22.71 
Calcium 
concentration 16.47 ±0.90 a 15.36 ± 1.01 b 13.42 ±1.60" 
(mg/dL) 
Liver Cholesterol 
4 7 . 7 7 土 1 2 . 8 0 5 1 . 0 7 土 2 5 . 5 8 4 3 . 2 2 土 10.：3：2 
(mg/g) 
Values are expressed as mean 士 S.D. (n=15). Means at the same row differ 
significantly at p<0.01 (a, b, c). 
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2.5.5 Effect of calcium on fecal neutral sterol output 
Concentration of neutral sterols in the feces of the hamsters at week 6 is shown 
in Table 2.9. There was no significant difference in total neutral sterol content in the 
feces of the three groups of hamsters. 
2.5.6 Effect of calcium on fecal acidic sterol output 
Concentration of fecal acidic sterol output is shown in Table 2.9. There was no 
significant difference in acidic sterol concentration among the three groups of 
hamsters. 
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Table 2.9 Effects of three diets on fecal neutral and acidic sterol output in the 
hamsters 
Ca 8g/kg Ca 2g/kg Ca Def 
Neutral Sterol (mg) 1.68 ± 0.77 1.88 ±1.16 1.20 ±0.48 
Acidic Sterol (mg) 0.97 土 0.43 0.87 土 0.58 0.79 ± 0.33 
Cholesterol intake (mg) 10.81 土 0.84 10.42 土 0.71 9.38 土 0.52 
Cholesterol retained (mg) 8.16 土 1.31 7.67 土 2.24 7.39 土 0.74 
Cholesterol 
7 5 . 5 2 土 1 0 . 4 0 7 2 . 9 2 士 1 8 . 1 0 7 8 . 8 9 ± 7 . 9 5 
retained/cholesterol intake (%) 
Values are expressed as mean 士 S.D. (n=15). 
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2.6 Discussion 
Golden Syrian hamster has been used as an experimental animal model in 
studying the efficacy of hypocholetserolemic agents in humans (Sugiyama et al, 1995; 
Terpstra et al, 1998). The major cholesterol carrier in blood in hamster is LDL which 
is similar to human plasma cholesterol distribution (Nistor et al, 1987). Moreover, 
biliary sterol secretion in hamster is similar to that in human (Spady & Dietschy, 
1985). Hamsters were chosen as an animal model because they have response similar 
to those of humans with respect to dietary influences on blood lipids. 
The present study showed all groups had similar body and organ weight, blood 
lipid profile, hepatic cholesterol and fecal excretion of neutral and acidic sterols in 
intact male and castrated hamsters. The present study used calcium phosphate dibasic 
as a substitution of calcium in diet. It was expected the total fecal sterol output should 
be decreased in the group without calcium, as dietary calcium and phosphate 
precipitate in the small intestine to form insoluble ACP (Ditscheid et al, 2005). 
However, the result showed both intact and castrated male hamsters had no effect on 
the fecal output, neutral and acidic sterol excretion. 
The diet given in the present study is deficient in calcium while the other studies 
which add calcium into the diet as a supplement, or as dairy product of calcium with 
the unsaturated fat (Pellizzon et al, 2004; Yacowitz et al, 1967; Zemel et al, 2000). 
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The weight of adipose tissue in both intact and castrated hamsters did not significantly 
change in the calcium deficient group. It is different from the previous animal study 
using transgenic mice (Zemel et al, 2000) which showed to reduce the weight gain 
and fat pad mass associated with a high calcium diet. The current study may be 
difficult to compare with the results from those of other studies due to different 
animal models used. 
The hypocholesterolemic potential of dietary calcium is not totally consistent 
among studies. Some studies show there is no significantly change on serum 
cholesterol when the diet is supplement with calcium or without calcium (Bostick et 
al, 2000; Mitchell et al, 1968). The age group, the diet of participants received and the 
duration of the experiment in the human studies are not identical. Nevertheless, it is 
concluded that dietary calcium does not have effect on blood lipoprotein profile in 
intact male and castrated hamsters. 
The normal bone formation occurred in hamsters fed diets containing 6.0g Ca/kg 
and rickets was produced in hamsters fed 4.7g Ca/kg. Old female hamsters fed diets 
containing 3.0, 5.0 or 7.0 g Ca/kg were in positive calcium balance only at the two 
higher calcium intakes. Thus, the amount of calcium in a normal diet for hamster was 
suggested in a range between 6.0 g Ca /kg diet to 8.0 Ca/kg (National Research 
Council U.S.A, 1995). This is similar to the ones that used in the investigation. 
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Chapter 3 
Effect of Calcium Deficiency and Inadequacy on 
Blood Cholesterol Level in Intact Female and 
Ovariectomized Hamsters 
3.1 Introduction 
Calcium supplementation is recommended and is used widely among 
postmenopausal women for the prevention of osteoporosis (Genant et cd, 1999). Other 
benefits associated with calcium supplementation have been suggested, including 
prevention colon cancer and reduction in blood pressure (Barger-Lux & Heaney, 
1994). Some human studies demonstrated that calcium improves the circulating lipid 
profile (Denke et al, 1993; Ditscheid et al, 2005; Jacqmain et al, 2003). Both sexes 
have been involved in the studies, however, female has shown a greater effect of 
dietary calcium on the lipid profile (Jacqmain et al, 2003). One study was conducted 
in normal postmenopausal women, (n = 223), who received calcium citrate for one 
year. HDL-C and HDL-C to LDL-C ratio have increased significantly (p<0.01) in the 
calcium group, whereas LDL-C was also declined, however, the change was not 
significant (Reid et al, 2002). 
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3.2 Objective 
Human observational studies have demonstrated a negative correlation between 
high calcium intake and blood cholesterol level. The previous chapter found the male 
and castrated hamsters did not have the negative correlation between calcium intake 
and blood cholesterol level. The objective of the study was therefore undertaken to 
ascertain if dietary calcium supplementation had any effect on blood cholesterol 
profile in intact female and ovariectomized hamsters. 
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3.3 Materials and methods 
3.3.1 Hamsters 
3.3.1.1 Intact female hamster 
Thirty-three female Syrian golden hamsters (100 - 110 g, age = 2 months, 
n= 11/group), were purchased from the Laboratory Animal Services Centre, The 
Chinese University of Hong Kong, and housed in wire-bottom cages at 23°C with a 
12-h light-dark cycle in the animal room. All the animals were stabilized on a 0.1% 
cholesterol with calcium adequate diet (8g/kg diet) for 2 weeks. Hamsters were 
divided into three groups similarly as previously described in section 2.3.1.1, and fed 
one of three diets containing 8g Ca/kg diet (Ca 8g/kg), 2g Ca/kg (Ca 2g/kg) and Og 
Ca/kg (Ca Def) for additional 6 weeks. All frozen diets were given daily, and uneaten 
portion was discarded. 
Blood collection and other experimental procedures were performed similarly as 
previously described in 2.3.1.1, Chapter 2. 
In brief, the small intestine was taken out with the first 5 cm of intestine being 
discarded. The lumen of the next 30 cm was flushed with ice cold PBS for 3 times, 
and opened longitudinally. The mucosal layer was scrapped off with a glass slide on 
ice and transferred into 10 mL of ice cold homogenizing buffer consisted of 0.05 M 
Tris at pH 7.8 with Complete ® protease inhibitor cocktail (Roche), and stored at 
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- 8 0 T until analysis. 
3.3.1.2 Ovariectomized hamster 
Similarly, thirty-six female hamsters (120 - 130g, age = 3 month, n=12/group) 
were ovariectomized. After a period of seven-day recovery, the ovariectomized 
hamsters were stabilized on a 0.1% cholesterol with calcium adequate diet (8 g/kg diet) 
for 2 weeks. For the next 6 weeks, hamsters were divided into three groups similarly 
as previously described in section 2.3.1.1. Blood collection and other experimental 
procedures were carried out similarly as previously described in 2.3.1.1, Chapter 2. 
3.3.2 Diets 
The ingredients were purchased and the diets were formulated as similarly as 
described section 2.3.2, Chapter 2. 
3.3.3 Determination of serum lipid, lipoproteins and calcium concentration 
The analyses were conducted in same way as previously described in section 
2.3.3, Chapter 2. 
3.3.4 Determination of cholesterol concentration in organs, fecal neutral and 
acidic sterols 
Materials and experimental procedures were described in section 2.3.4 to 2.3.7, 
Chapter 2. 
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3 � 5 Western blottting of liver SREBP-2, LDLR, HMGR, LXR and CYP7A1 
proteins 
Total hepatic proteins were extracted according to the method described by 
Vaziri & Liang (1996) with some modifications. In brief, frozen liver was 
homogenized in a buffer containing 20mM Tris-HCl (pH 7.5), 2mM MgCl^, 0.2M 
sucrose and Complete® protease inhibitor cocktail (Roche, Mannheim, Germany). 
The extract was centrifuged at 13,000 g for 10 minutes at 4 and the supernatant 
was collected as the 'total proteins'. A portion of the total proteins was then 
centrifuged at 12,600 g for one hour at 4 The supernatant was removed and the 
pellet was, 'membrane proteins', resuspended in the buffer described above. Protein 
concentration of the two fractions was determined using a protein assay kit (Bio-Rad, 
Hercules, CA, USA). 
For the measurement of LDLR, CYP7A1, LXR, SREBP-2 and HMGR, 100|ig of 
the membrane protein was size-fractionated on a 7 % SDS-PAGE gel at 130V for one 
hour. The proteins were then transferred to Immobilon-P PVDF membrane (Millipore 
Corporation, USA). Blocking solution (5% nonfat milk in IX TBST) was used for the 
one hour incubation and then overnight in the same solutions containing 1:600 
anti-LDL receptor antibody (Calbiochem, USA), 1:200 anti-CYP7Al (Santa Cruz 
Biotechnology, California, USA), 1:400 anti-LXR antibody (Santa Cruz 
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Biotechnology), 1:400 anti-SREBP-2 antibody (Santa Cruz Biotechnology) or 1:500 
anti-HMGR (Upstate USA Inc., Lake Placid, NY, USA) as primary antibody 
whichever appropriate. 
The membrane was then washed three times for 15 minutes in 1 x TBST and 
incubated for one hour at 4 in diluted (1:3000) horseradish peroxidase-linked 
rabbit anti-goat IgG (Zymed Laboratories Inc., San Francisco, CA, USA) or donkey 
anti-rabbit IgG (Santa Cruz Biotechnology). The washes were repeated before the 
membranes were developed with enhanced chemiluminescence (ECL) agent (Santa 
Cruz Biotechnology) and subjected to autoradiography for one to five minutes on 
S u p e r / ^ medical X-ray film (Fuji, Tokyo, Japan). Densitometry was quantified using 
the computer software Photoshop® (Adobe Systems Inc, CA, USA). 
3.3.6 Preparation of intestinal microsome 
The mucosa sample was thawed and then homogenized in a homogenizer 
(Wheaton, San Diego, CA, USA) on ice. The mixture was centrifuged at 800 g for 15 
minutes at The supernatant containing the cytosol was transferred to a new vial 
and the pellet was discarded. The supernatant was centrifuged again. The resultant 
supernatant was transferred to a polycarbonate centrifuge tube (Beckman) and 
centrifuged at 100,000 g for 60 minutes at 4 °C. The supernatant was discarded and 1 
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mL homogenizing buffer (0.05 M Tris, 1 M KCl, with Complete ® protease inhibitor 
cocktail (Roche)) was used to resuspend the pellet as the microsome. CHAPS (Sigma) 
was added with constant mixing to final concentration of 2% (w/v) and stored at -80 
until analysis. Aliquot of the microsome was taken for determination of protein 
concentration using a commercial protein assay kit (Bio-rad). 
3.3.7 Intestinal acyl coenzyme A: cholesterol acyltransferase (ACAT) activity 
measurement 
Intestinal ACAT activity was measured as described previously by Cadigan & 
Chang (1988); Chang et al (2000); Zhang (2003). Microsome was adjusted with a 
solubilization buffer to a protein concentration of 1 mg/ 150 |iL. Cholesterol in 45% 
(w/v) 2-hydroxypropyl p-cyclodextrin aqueous solution (400 nmol) was added into 1 
mg of microsome and incubated on ice for 30 minutes and then in a 37 °C water bath 
for 5 minutes to equalize temperature. The reaction was initiated by adding an assay 
reagent of 0.517 nmol of [14C] oleoyl-Coenzyme A (0.03|iCi) (Perkin-Elmer, 
Waltham, MA, USA), 7.483 nmol of non-radioactive oleoyl-Coenzyme A (Sigma) and 
10 nmol of fatty acid-free bovine serum albumin (Sigma) followed by incubation in a 
37 °C water bath for 20 minutes. The reaction was stopped by adding 4.8 mL 
chloroform: methanol mixture (2:1, v/v) and 1 mL saline and then chilling on ice. 
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After the addition of 10 [ig [3H] cholesterol oleate (0.002 |iCi) (as internal standard 
for loss correction), the mixture was centrifuged at 800 g for 10 minutes at 4 and 
the lower organic layer was collected and evaporated under a gentle nitrogen stream 
until dryness. Cholesteryl oleate (10|ig) in 50 [iL of chloroform was added and the 
tube was vortexed thoroughly. The resuspension was spotted on a thin-layer 
chromatography (TLC) plate (Merck, NJ, USA) and then developed in hexane: ethyl 
acetate: acetic acid (80:20: 1, v/v) for 45 minutes. The plate was dried and stained in 
iodine vapor. The band corresponding to cholesterol oleate was cut off according to a 
cholesteryl oleate standard developed in parallel and transferred to a scintillation vial. 
Containing 10 mL of OptiPhase HiSafe 2 scintillation fluid (Perkin-Elmer) and the 
mixture was incubated with agitation overnight. Radioactivity was measured in an LS 
6500 scintillation counter (Beckman) and the data were calculated based on [3H； 
recovery. 
3.3.8 Statistics 
Results were presented as means 士 standard deviation (S.D.). The analysis of 
variance (ANOVA) followed by student's t-test (two-tailed) was used for statistical 
evaluation. Differences between groups were considered significant when p<0.05. 
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3.4 Results on intact female hamsters 
3.4.1 Growth and food intake 
The body weight and food intake are shown in Table 3.1. No significant 
differences were observed among the Ca Def, Ca 2 g/kg and Ca 8 g/kg groups. 
3.4.2 Organ weights 
The weights of liver, kidney, heart and adipose tissue are shown in Table 3.2. 
There were no significant differences in organs weights among the three groups. 
3.4.3 Effect of calcium deficiency diet on the plasma lipid profile and calcium 
concentration of hamsters 
Plasma TC (p<0.05), TG (p<0.01), nHDL-C (p<0.01) and nHDL-C/HDL-C 
(p<0.01) of the Ca 8 g/kg were significantly lower than those of Ca Def group (Table 
3.3). TC/HDL-C of the Ca 8 g/kg was significantly lower than that of Ca 2 g/kg group 
(p< 0.01) and Def group (p< 0.01). HDL-C and calcium concentration of the Ca 8 
g/kg group was significantly higher than that of the other two groups (p< 0.01). 
3.4.4 Effect of calcium deficiency diet on hepatic cholesterol of hamsters 
The hepatic cholesterol in Ca 8g/kg group was significantly lower (p<0.01) than 
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that in Ca Def group. There was no significant difference in the hepatic cholesterol 
between Ca 8g/kg and Ca 2g/kg groups (Figure 3.1). 
3.4.5 Effect of dietary calcium on fecal neutral sterol output 
Concentration of fecal neutral sterols in intact female hamsters at week 6 is 
shown in Table 3.4. There was no significant difference in total fecal neutral sterol 
content of intact female hamsters fed the Ca Def, Ca 2g/kg and Ca 8g/kg diets. 
3.4.6 Effect of dietary calcium on fecal acidic sterol output 
Concentration of total fecal acidic sterol output is shown in Table 3.4. The acidic 
sterol output in Ca 8g/kg group was significantly higher than that in the Def group 
(p<0.05). The cholesterol retained and the ratio of cholesterol retained to cholesterol 
intake ratio were significantly lower in the Ca 8g/kg group when compared with that 
in the Def group (p<0.05). There was no significant difference in cholesterol intake in 
hamsters among the three groups of hamsters. 
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Table 3.1 Body weight gain and food intake of three groups of intact female 
hamsters fed the calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g 
calcium/kg (Ca 8g/kg) diets. 
Ca 8g/kg Ca 2g/kg Ca Def 
Initial body weight (g) 104.55 ±9.07 106.36 ± 10.27 101.36 ±9.24 
Final body weight (g) 125.91 ± 15.78 137.73 ± 14.55 136.36 ±12.67 
Food intake (g/day) 11.81±1.62 12.70±1.69 11.83±1.00 
Values are expressed as mean 士 S.D. (n=ll). 
Table 3.2 Weights of liver, heart, kidney and adipose tissue of three groups of intact 
female hamsters fed the calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g 
calcium/kg (Ca 8g/kg) diets. 
Ca 8g/kg Ca 2g/kg Ca Def 
Liver (g) 6.75 ± 1.27 7.31 ± 1.05 6.89 ±1.05 
Heart (g) 0.50 土 0.06 0.50 土 0.07 0.48 土 0.04 
Kidney (g) 1.40 ±0.19 1.50 ±0.11 1.40 ±0.11 
Adipose 
1.26 ±0.50 1.44 ±0.75 1.34 ±0.42 
Tissue (g) 
Values are expressed as mean 士 S.D. (n二 11). 
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Table 3.3 Effects of feeding the calcium deficiency diet (Ca def), 2g calcium/kg (Ca 
2g/kg) and 8g calcium/kg (Ca 8g/kg) diets on the plasma total cholesterol (TC), 
high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (nHDL-C), the 
ratio of nHDL-C to HDL-C, triglycerides (TG) and calcium concentration in the intact 
female hamsters at week 6 
Ca 8g/kg Ca 2g/kg Ca Def 
TC (mg/dL) 188.82 ± 25.12 b 205.19 ± 30.33 "b 226.52 ± 53.08 a 
HDL-C (mg/dL) 9 6 . 7 7 土 5 . 5 0 ^ 8 8 . 5 6 土 6 . 2 0 ‘ 8 9 . 0 3 土 6 . 0 4 ^ 
Non HDL-C (mg/dL) 99.86 土 23.21 d 116.62 士 31.07 ^^  146.85 土 41.58 ‘ 
Non HDL-C/HDL-C 1.05 ± 0.25 d 1.33 ± 0 . 3 9 � � 1.64 ± 0.44' 
TC/HDL-C 1.96 ± 0.31 d 2.33 ±0.39" 2.54 ± 0.53' 
Triglyceride (mg/dL) 93.86 土 14.15� 105.32 土 2 3 . 5 5 � � 120.26 土 27.58 ‘ 
Calcium 
concentration 15.32 ±1 .17 ' 13.83 ± 0 . 7 5 � 12.64 ± 0.90 e 
(mg/dL) 
Values are expressed as mean 士 S.D. (n=ll). 
Means at the same row differ significantly at p<0.05 (a, b) and p<0.01 (c, d, e). 
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Figure 3.1 The hepatic cholesterol of three groups of intact female hamsters fed the 
calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g calcium/kg (Ca 8g/kg) 
diets. Values are expressed as mean 士 S.D. (n=ll). Means at the same row with 
different superscripts (a, b) differ significantly at p<0.01. 
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Table 3.4 Effects of three diets on fecal neutral and acidic sterol output in the 
hamsters fed the calcium deficient diet (Ca def), 2g calcium/kg (Ca 2g/kg) and 8g 
calcium/kg (Ca 8g/kg) diets 
Ca 8g/kg Ca 2g/kg Ca Def 
Neutral Sterol (mg) 3.39 ± 1.48 1.83 土 0.44 2.02 土 1.03 
Acidic Sterol (mg) 4.29 ± 1.87a 1 . 3 0 ± 0 . 9 3 匕 ' 0 . 8 8 ±0 .01� 
Cholesterol intake (mg) 11.40 ±2.08 11.95 土 1.11 10.76 ±0.57 
Cholesterol retained (mg) 5.08 土 2.78b g gg 土 2.24a 士 l.67a 
Cholesterol 
retained/cholesterol 44.58 土 23.63a 71.48 土 15.00匕。75.14 土 7.45� 
intake (%) 
Values are expressed as mean 士 S.D. (n=ll). Means at the same row with different 
superscripts (a, b, c) differ significantly at p<0.05. 
70 
3.4.7 Effect of dietary calcium on liver LDLR immunoreactive mass 
The Western Blot analysis showed that liver LDLR immunoreactive mass did not 
differ among the Ca 8g/kg, Ca 2g/kg and Ca Def groups (Figure 3.2). 
3.4.8 Effect of dietary calcium on liver CYP7A1 immunoreactive mass 
No difference in liver CYP7A1 immunoreactive mass was observed among the 
Ca 8g/kg, Ca 2g/kg and Ca Def groups (Figure 3.3). 
3.4.9 Effect of dietary calcium on liver LXR immunoreactive mass 
The Western Blot analysis demonstrated that liver LXR immunoreactive mass 
did not differ among the Ca 8g/kg, Ca 2g/kg and Ca Def groups (Figure 3.4). 
3.4.10 Effect of dietary calcium on liver SREBP-2 immunoreactive mass 
Similarly, Western Blot analysis showed liver SREBP-2 immunoreactive mass 
did not differ among the Ca 8g/kg, Ca 2g/kg and Ca Def groups (Figure 3.5). 
3.4.11 Effect of dietary calcium on liver HMGR immunoreactive mass 
The Western Blot analysis revealed that liver HMGR immunoreactive mass did 
not differ among the Ca 8g/kg, Ca 2g/kg and Ca Def groups (Figure 3.6). 
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Figure 3.2 Normalization of immunoreactive mass abundance of LDLR with 
P-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of the Ca 8 
g/kg group is regarded as 1.0. Values are expressed as means 士 S.D. (n=l 1). 
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Figure 3.3 Normalization of immunoreactive mass abundance of CYP7A1 with 
P-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of the Ca 8 
g/kg group is regarded as 1.0. Values are expressed as means 土 S.D. (n=ll). 
73 




•D 1 . 2 -
C T 
















O 0.0 ‘ ‘ ‘ 
^ Ca 8g/kg Ca 2g/kg Ca Def 
LXR imtmnmm mmmmmn 
P-tubulin 〜—愈 
Figure 3.4 Normalization of immunoreactive mass abundance of LXR with 
3-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of the Ca 8 
g/kg group is regarded as 1.0. Values are expressed as means 士 S.D. (n二 11). 
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Figure 3.5 Normalization of immunoreactive mass abundance of SREBP-2 with 
P-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of the Ca 8 
g/kg group is regarded as 1.0. Values are expressed as means 土 S.D. (n=ll). 
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Figure 3.6 Normalization of immunoreactive mass abundance of HMGR with 
3-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of the Ca 8 
g/kg group is regarded as 1.0. Values are expressed as means 土 S.D. (n=ll). 
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3.4.12 Effect of dietary calcium deficiency on intestinal ACAT activity 
The intestinal ACAT activity in the Ca 8g/kg group was significantly lower (p< 
0.01) than that of Ca 2g/kg and Ca Def group (Figure 3.7). There was no difference in 
intestinal ACAT activity between the Ca 2g/kg and Ca Def groups. 
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Figure 3.7 Effect of calcium deficiency on intestinal Acyl Coenzyme A: Cholesterol 
Acyltransferase (ACAT) activity. Hamsters were fed one of the three diets: calcium 
deficient diet (Ca def), 2g calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 
8g/kg). Values are expressed as means 土 S.D. (n=ll). Means with different 
superscripts (a, b) differ significantly at p<0.01. 
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3.5 Results on ovariectomized hamsters 
3.5.1 Growth and food intake 
The body weight and food intake are shown in Table 3.5. No significant 
differences were observed among the Ca Def, Ca 2g/kg and Ca 8 g/kg groups. 
3.5.2 Organ weights 
The weights of liver, kidney, heart and adipose tissue are shown in Table 3.6. 
There were no significant differences in organs weights among the three groups. 
3.5.3 Effect of calcium deficiency diet on plasma lipid profile and calcium 
concentration of hamsters 
Plasma TC (p<0.05), nHDL-C (p<0.05), nHDL-C/HDL-C (p<0.01) and 
TC/HDL-C (p<0.01) in the Ca 8g/kg group were significantly lower than the Def 
group. HDL-C (p< 0.05) and calcium concentration (p< 0.01) of the Ca 8g/kg was 
significantly higher than the other groups. TG in hamsters fed no calcium diets was 
not significantly different from that of the control. Result has been shown in Table 
3.7. 
3.5.4 Hepatic cholesterol 
The hepatic cholesterol of the Ca 8g/kg group is significantly lower (p<0.05) 
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than the Ca Def group. There is no significant difference of the hepatic cholesterol 
between Ca 8g/kg and Ca 2g/kg groups (Figure 3.8). 
3.5.5 Effect of dietary calcium on fecal neutral sterol output 
Concentration of neutral sterols in the feces of ovariectomized hamsters at week 
6 is shown in Table 3.8. The total fecal neutral sterol content was significantly higher 
in the Ca 8g/kg group than the Def group (p<0.05). However, no difference in fecal 
output of neutral sterols was seen between Ca 8g/kg and Ca 2g/kg groups. 
3.5.6 Effect of dietary calcium on fecal acidic sterol output 
Concentration of fecal acidic sterol output is shown in Table 3.8. The acidic 
sterol output of the Ca 8g/kg group was significantly higher than the Ca Def group 
(p<0.05) but it was not significantly different from that of Ca 2g/kg group. The 
cholesterol retained and the ratio of cholesterol retained to cholesterol intake ratio 
were significantly lower in the Ca 8g/kg group when compared with the Ca Def group 
(p<0.05). However, no difference in these parameters was observed between the two 
calcium supplement groups. There was no significant difference in cholesterol intake 
among the three groups of ovariectomized hamsters. 
80 
Table 3.5 Body weight gain and food intake of three groups of ovariectomized 
hamsters fed the calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g 
calcium/kg (Ca 8g/kg) diets. 
Ca 8g/kg Ca 2g/kg Ca Def 
Initial body weight (g) 125.40 ± 14.69 127.50 ±9.41 120.80 ± 11.65 
Final body weight (g) 133.60 ± 12.27 140.20 ± 12.22 135.00 土 10.66 
Food intake (g/day) 11.78±1.56 12.72±0.93 12.33±1.03 
Values are expressed as mean 士 S.D. (n=12). 
Table 3.6 Weights of liver, heart, kidney and adipose tissue of three groups of 
hamsters fed the calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g 
calcium/kg (Ca 8g/kg) diets. 
Ca 8g/kg Ca 2g/kg Ca Def 
Liver (g) 5.38 土 0.66 5.68 土 0.83 5.11 土 0.57 
Heart (g) 0.53 土 0.06 0.52 土 0.06 0.53 土 0.02 
Kidney (g) 1.39 ± 0.07 1.39 ±0.13 1.31 ±0.07 
Adipose Tissue (g) 0.80 ± 0.24 1.15 ± 0.37 0.99 ± 0.26 
Values are expressed as mean 士 S.D. (n=12). 
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Table 3.7 Effects of feeding the calcium deficiency diet (Ca def), 2g calcium/kg (Ca 
2g/kg) and 8g calcium/kg (Ca 8g/kg) diets on the plasma total cholesterol (TC), 
high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (nHDL-C), the 
ratio of nHDL-C to HDL-C, triglycerides (TG) and calcium concentration in the 
ovariectomized hamsters at week 6 
Ca 8g/kg Ca 2g/kg Ca Def 
TC (mg/dL) 211.76 ± 34.52 b 231.62 ± 20.68 ab 241.42 ± 26.69 a 
HDL-C (mg/dL) 110.35 ± 7.92a 100.64 ± 10.02ab 99.60 ± 13.43 b 
Non HDL-C (mg/dL) 102.69 ± 32.10 b 130.98 ± 17.13 ab 142.22 ± 33.92 a 
Non HDL-C/HDL-C 0.94 ± 0.27 d 1.31 ± 0.21 " 1.48 ± 0.53 " 
TC/HDL-C 1.94 ± 0.27 d 2.31 ± 0.21 " 2.48 ± 0.53" 
Triglyceride (mg/dL) 110.70 土 34.36 130.13 土 33.54 140.00 土 33.10 
Calcium 
concentration 14.70 ± 0.92 ' 13.82 ± 0.42 d 13.24 ± 0.51 e 
(mg/dL) 
Values are expressed as mean 土 S.D. (n=12). 
Means at the same row differ significantly at p<0.05 (a, b) and p<0.01 (c, d, e). 
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Figure 3.8 The hepatic cholesterol of three groups of ovariectomized hamsters fed 
the calcium deficient (Ca Def), 2g calcium/kg (Ca 2g/kg) and 8g calcium/kg (Ca 
8g/kg) diets. Values are expressed as mean 士 S.D. (n=12). Means at the same row 
with different superscripts (a, b) differ significantly at p<0.05. 
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Table 3.8 Effects of three diets on fecal neutral and acidic sterol output in the 
ovariectomized hamsters fed the calcium deficient diet (Ca def), 2g calcium/kg (Ca 
2g/kg) and 8g calcium/kg (Ca 8g/kg) diet 
Ca 8g/kg Ca 2g/kg Ca Def 
Neutral Sterol (mg) 3.55 土 0.47 “ 2.44 土 0.75 1.39 土 0.94 b 
Acidic Sterol (mg) 2.80 ±1.23 a 1.46 1 0.47 ab 0.85 ± 0.44 b 
Cholesterol intake (mg) 11.07 ± 1.43 12.98 ±0.74 12.68 ±2.31 
Cholesterol retained 
4.87 ± 3.06 b 9.08 ± 1.67 ab 10.81 ±2.03 a 
(mg) 
Cholesterol 
retained/cholesterol 42.09 ± 21.95 b 69.74 土 10.36 85.46 土 6.66 ‘ 
intake (%) 
Values are expressed as mean 土 S.D. (n=12). 
Means at the same row with different superscripts (a, b) differ significantly at p<0.05. 
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3.5.7 Effect of dietary calcium on liver LDLR immunoreactive mass 
The Western Blot analysis demonstrated that liver LDLR immunoreactive mass 
did not differ among the three groups (Figure 3.9). 
3.5.8 Effect of dietary calcium on liver CYP7A1 immunoreactive mass 
The Western Blot analysis showed that liver CYP7A1 immunoreactive mass did 
not differ among the Ca 8g/kg, Ca 2g/kg and the Ca Def groups (Figure 3.10). 
3.5.9 Effect of dietary calcium on liver LXR immunoreactive mass 
The Western Blot analysis revealed that liver LXR immunoreactive mass was not 
different among the Ca 8g/kg, Ca 2g/kg and the Ca Def groups (Figure 3.11). 
3.5.10 Effect of dietary calcium on liver SREBP-2 immunoreactive mass 
The Western Blot analysis did not found that liver SREBP-2 immunoreactive 
mass was different among the Ca 8g/kg, Ca 2g/kg and the Ca Def groups (Figure 
3.12). 
3.5.11 Effect of dietary calcium on liver HMGR immunoreactive mass 
The Western Blot analysis found liver HMGR 2 immunoreactive mass was not 
different among the Ca 8g/kg, Ca 2g/kg and the Ca Def groups (Figure 3.13). 
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Figure 3.9 Normalization of immunoreactive mass abundance of LDLR with 
p-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of Ca 8g/kg 
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Figure 3.10 Normalization of immunoreactive mass abundance of CYP7AI with 
p-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of Ca 8g/kg 
group is regarded as 1.0. Values are expressed as means 士 S.D. (n=12). 
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Figure 3.11 Normalization of immunoreactive mass abundance of LXR with 
p-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of the Ca 
8g/kg group is regarded as 1.0. Values are expressed as means 士 S.D. (n=12). 
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Figure 3.12 Normalization of immunoreactive mass abundance of SREBP-2 with 
3-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of the Ca 
8g/kg group is regarded as 1.0. Values are expressed as means 土 S.D. (n=12). 
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Figure 3.13 Normalization of immunoreactive mass abundance of HMGR with 
3-tubulin. Hamsters were fed one of the three diets: calcium deficient diet (Ca def), 2g 
calcium/kg diet (Ca 2g/kg) and 8g calcium/kg diet (Ca 8g/kg). The value of the Ca 
8g/kg group is regarded as 1.0. Values are expressed as means 土 S.D. (n=12). 
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3.6 Discussion 
The present study examined the association between calcium intake and plasma 
lipid profile in intact female and ovariectomized hamsters. The results demonstrated 
an inverse relationship between calcium intake and blood cholesterol in female and 
ovariectomized hamsters but not in intact male and castrated hamsters. It appeared 
that calcium deficiency diet had greater impact on intact female than ovariectomized 
hamster. 
Calcium supplementation has shown to affect serum lipid concentration in 
humans (Bhattacharyya et al, 1969; Denke et al, 1993; Ditscheid et al, 2005; 
Jacqmain et al, 2003; Reid et al, 2002; Yacowitz et al, 1965) and in some animal 
models (Pellizzon et al, 2004; Zemel et al’ 2000). However, the underlying 
mechanism by which calcium affect serum lipids remains unknown. 
The body weight and adipocytes of transgenic mice, which express the agouti 
gene, increased when calcium was low in diets (Zemel, 1998). A low calcium diet 
stimulated the rate of lipogenesis and suppressed that of lipolysis. Intracellular 
calcium concentration appears to play an important role in obesity, as it was found to 
regulate both lipogenesis and lipolysis in human adipocytes (Zemel, 1998). Compared 
with these data, the body weight and organ weight, especially the adipose tissue, of 
the intact female and ovariectomized hamsters were not significantly increased in the 
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calcium deficiency group. It can only be concluded that an increase in blood 
cholesterol level associated with a calcium deficient diet is due to a decrease in fecal 
cholesterol output. 
Liver is the major site for elimination of cholesterol from the body through bile. 
The cholesterol in the liver is converted into bile acids or directly secreted into bile as 
biliary cholesterol. Liver also produces VLDL, and is a major catabolic site for LDL 
through the LDL receptor-mediated pathway (Spady et al, 1983; Spady & Dietschy, 
1985). There is no evidence to show calcium could affect proteins including SREBP-2, 
LDLR, HMGR, LXR and CYP7A1, all of which have a role in regulation of the input 
and output of cholesterol in the liver. The experimental result on female hamsters 
showed the blood cholesterol was decreased while the fecal cholesterol output was 
increased in calcium-supplemented hamsters. The underlying mechanism is possibly 
due to the inhibition on intestinal ACAT and thus the decrease in cholesterol 
absorption. In contrast, intestinal ACAT activity was significantly increased (p<0.01) 
in the calcium deficiency group compared with the calcium adequate group. Reducing 
cholesterol absorption essentially reduces the incorporation and influx of cholesterol 
into the body. The present study suggest that cholesterol-lowering activity in hamsters 
fed a Ca 8g/kg diet be mediated at least in part by suppression on intestinal ACAT 
activity. 
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It remains unknown why dietary calcium has cholesterol-lowering activity in 
female and ovariectomized hamsters but it has little effect in male and castrated 
hamsters. It is known female rats consistently ingest more calcium than do males. 
This is not affected by the ovariectomization or castration that carried out after the 
neonatal period (Schulkin, 2001). Intact female and ovariectomized hamsters may be 
more sensitive to the change of the calcium in the diet than male. 
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Chapter 4 
Effect of Dietary Magnesium Supplementation 
on Blood Cholesterol Level in Intact Male 
Hamsters 
4.1 Introduction 
Calcium and magnesium are the essential minerals which involve in many 
functions in humans. One of the effects is that magnesium intake may play a role in 
modulation of serum lipid profile in animal and human studies. This view has been 
supported by numerous experimental and epidemiologic studies (Olatunji & Soladoye, 
2007; Ouchi et al, 1990; Rayssiguier et al, 1981; Witteman et al, 1994). 
In a six-month experiment with rabbit that fed a high cholesterol diet, dietary 
magnesium lowered serum TC and reduced the accumulation of cholesterol in aorta 
(Renaud et al, 1983). Male rats fed a magnesium deficient and high carbohydrate diet 
increased serum TG and significantly lowered the HDL-C compared with the control 
group (Rayssiguier et al, 1981). Increasing magnesium intake could reduce serum TG, 
phospholipids, HDL-C and TC in the 4-week-old female Wistar rats. An increase 
trend in HDL-C to TC ratio was observed in rats fed a high magnesium intake 
(Takeda & Nakamura, 2008). However, contradictory results showed in male rabbits, 
additional magnesium did not affect serum cholesterol and HDL-C concentrations 
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(Ouchi et al 1990). 
The regulation of HMGR activity involves long and short term mechanisms; the 
short term control is by means of covalent modification and requires magnesium. 
There is a proposed mechanism that magnesium deficiency could affect the blood 
cholesterol profile of hamster. Magnesium deficiency keep activated HMGR in active 
state as phosphorylation cannot occur. Thus, inactivation of HMGR cannot occur 
without magnesium. Magnesium also attenuate the activity of lecithin cholesterol acyl 
transterase (LCAT), which lowers serum LDL-C and TG levels, and raises HDL-C 
levels (Rosanoff & Seelig, 2004). 
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4.2 Objective 
The previous study demonstrated the modulating effect of calcium on blood lipid 
profile in female and ovariectomized hamsters. Therefore, it is of interest to ascertain 
whether the magnesium has the similar effect on blood lipid profile as calcium. The 
objective of the study was undertaken to study effect of dietary magnesium 
supplementation on blood cholesterol profile in intact male hamsters. 
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4.3 Materials and methods 
4.3.1 Hamsters 
Forty-four (100 — 115 g, age = 2 months) male Syrian golden hamsters 
{Mesocricetus auratus), were randomly divided into four groups (n= 11/group) and 
housed in wire-bottom cages at 23°C with a 12-h light-dark cycle in an animal room. 
All the hamsters were stabilized on a 0.1% cholesterol diet with a magnesium 
adequate diet (0.5g Mg/kg diet, Mg 0.5g/kg) for 2 weeks. All Frozen diets were given 
to hamsters daily, and uneaten portion was discarded. From week 0 to week 6, one 
group continued to be maintained on the magnesium adequate diet, the other three 
groups received the diets similar to the magnesium adequate diet except that they 
contained 1.5g Mg/kg diet (Mg 1.5g/kg), l.Og Mg/kg diet (Mg l.Og/kg) and 0.05g 
Mg/kg diet (Mg 0.05g/kg). The hamsters were allowed freely to access the food and 
tap water ad libitum. Food intake was measured daily and body weight was recorded 
weekly. The total fecal output of each hamster was separated from other bedding 
materials and was pooled in each week throughout the experiment. 
Blood collection schedule and other experimental procedures were performed 
similarly as previously described in section 2.3.1.1. 
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4.3.2 Diets 
The ingredients were purchased from Harlan Teklad (Madison, WI, USA) except 
for lard, which obtained from the local market. DL-methionine, cholesterol were 
purchased from Sigma Chemical (St. Louis, MO, USA). 
The basal diet was prepared by mixing the following ingredients in proportion 
(g/kg diet): cornstarch, 508; casein, 242; lard, 50; sucrose, 119; magnesium deficiency 
mineral mix AIN-76, 40; vitamin mix AIN-76A, 20; DL-methionine, 1; cholesterol, 1. 
The four experimental diets was prepared by adding 2.48g Magnesium oxide (MgO) 
(High), 1.66g MgO (Medium), 0.96g MgO (Adequate) and 0.096g MgO (Deficiency) 
into the basal diet, respectively. The powdered diets were then mixed with gelatin 
solution (20g/L) respectively (Table 4.1). Once the gelatin had set, the food was cut 
into 15g cubed portions and stored in a freezer at -20°C. 
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Table 4.1 The composition of four diets containing Mg 1.5g/kg (High), Mg 1.0g/kg 
(Medium), Mg 0.5g/kg (Adequate) and Mg 0.05 g/kg (Deficiency). 
Mg 1.5g/kg Mg 1.0g/kg Mg 0.5g/kg Mg 0.05g/kg 
Ingredient 
(High) (Medium) (Adequate) (Deficiency) 
Constarch 508 508 508 508 
Casein 242 242 242 242 
Sucrose 119 119 119 119 
Lard 50 50 50 50 
Magnesium Deficiency 
40 40 40 40 
mineral mix (AIN-76) 
Vitamin mix (AIN-76A) 20 20 20 20 
Gelatin 20 20 20 20 
DL- Methionine 1 1 1 1 
Cholesterol 1 1 1 1 
Magnesium oxide 2.48 1.66 0.96 0.096 
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4.3.3 Determination of serum lipid, lipoproteins and magnesium concentration 
Materials and experimental procedures were as same as those previously 
described in section 2.3.3, Chapter 2. Magnesium concentration was measured using 
commercial kits from Stanbio Laboratories (Boeme, TX, USA). 
4.3.4 Determination of cholesterol concentration in organ, fecal neutral and 
acidic sterols 
Materials and experimental procedures were described in section 2.3.4 to 2.3.7, 
Chapter 2. 
4.3.5 Statistics 
Results were presented as means 土 standard deviation (S.D.). The analysis of 
variance (ANOVA) followed by student's t-test (two-tailed) was used where 
applicable for statistical evaluation. Differences between groups were considered 
significant when p<0.05. 
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4.4 Results on male hamster 
4.4.1 Growth and food intake 
The deficiency group showed dramatic reduction in body weight and food intake 
since week 1 and most hamsters died at week 5. The data on the deficient group are 
therefore not included in the study. The other groups continued to be maintained on 
their respective diet. The body weight and food intake are shown in Table 4.2. No 
significant differences were observed among the Mg 1.5g/kg, Mg 1 .Og/kg and Mg 0.5 
g/kg groups. 
4.4.2 Organ weights 
The weights of liver, kidney, heart and adipose tissue are shown in Table 4.3. 
There were no significant differences in organs weights among the three groups. 
4.4.3 Effect of dietary magnesium on plasma lipid profile and magnesium 
concentration in hamsters 
Plasma TC, HDL-C, nHDL-C in hamsters fed diets containing the three levels of 
magnesium did not significantly differ (Table 4.4). Serum TG increased significantly 
with the increasing magnesium in diet (p<0.05). Plasma magnesium concentration in 
hamsters in Mg 0.5 g/kg group decreased significantly when compared with Mg 
1.5g/kg (p<0.01) and Mg 1.Og/kg groups (p<0.01). 
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4.4.4 Effect of dietary magnesium on hepatic cholesterol of hamsters 
There was no significant difference in hepatic cholesterol among the three 
groups (Table 4.4). 
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Table 4.2 Body weight gain and food intake of the three groups of hamsters fed 
diets containing 1.5 g magnesium/kg (Mg 1.5g/kg), l.Og magnesium/kg (Mg l.Og/kg) 
and 0.5g magnesium/kg (Mg 0.5g/kg). 
Mg 1.5g/kg Mg 1.0g/kg Mg 0.5g/kg 
(High) (Medium) (Adequate) 
Initial body weight (g) 110.00 土 8.06 113.20 ±8.15 113.60 土 5.95 
Final body weight (g) 131.40 ± 10.02 133.20 ± 15.54 137.30 ±9.32 
Food intake (g/day) 10.93±0.87 11.37±0.95 11.36±1.09 
Values are expressed as mean 士 S.D. (n=l 1). 
Table 4.3 Weights of liver, heart, kidney and adipose tissue of hamsters fed diets 
containing 1.5 g magnesium/kg (Mg 1.5g/kg), l.Og magnesium/kg (Mg l.Og/kg) and 
0.5g magnesium/kg (Mg 0.5g/kg). 
Mg 1.5g/kg Mg 1.0g/kg Mg 0.5g/kg 
(High) (Medium) (Adequate) 
Liver (g) 4.91 土 0.64 4.87 土 0.81 4.88 土 0.39 
Heart (g) 0.55 ± 0.29 0.46 ± 0.05 0.47 ± 0.03 
Kidney (g) 1.06 ± 0.04 1.09 ± 0.12 1.17 ± 0.07 
Adipose 
2 . 1 2 土 0 . 4 5 2 . 1 8 土 0 . 5 3 2 . 0 4 土 0 . 4 8 
Tissue (g) 
Values are expressed as mean 士 S.D. (n=l 1). 
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Table 4.4 Effects of feeding the 1.5g magnesium/kg diet (high), l.Og magnesium/kg 
diet (medium) and 0.5g magnesium/kg diet (adequate) on plasma total cholesterol 
(TC), high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (nHDL-C), 
the ratio of nHDL-C to HDL-C, triglycerides (TG), magnesium concentration and 
hepatic cholesterol in hamsters at week 6 
Mg 1.5g/kg Mg 1.0g/kg Mg 0.5g/kg 
(High) (Medium) (Adequate) 
TC (mg/dL) 239.89 ± 28.73 248.82 ± 32.52 224.19 ±33.95 
HDL-C (mg/dL) 121.41 ±21 .31 1 2 3 . 9 7 ±21.09 120.99 ±11 .25 
Non HDL-C (mg/dL) 118.48 土 18.20 1 2 0 . 7 8 土 1 9 . 0 0 1 0 3 . 2 0 土 33.47 
Non HDL-C/HDL-C 1.00 ±0.19 1.00 ±0.24 0.86 ± 0.32 
TC/HDL-C 2.00 ± 0.19 2.00 ± 0.24 1.86 ± 0 . 3 2 
Triglyceride (mg/dL) 181.21 ± 48.2ia 172.27 ± 83.20ab 140.61 ± 39.46匕 
Magnesium 
concentration 3.13 ± 0.11" 2.79 ±0.24" 2.50 ± 0 . 1 5 � 
(mEq/L) 
Liver Cholesterol 
46.79 ±3.71 47.55 ± 5.56 43.68 ± 4.60 
(mg/g) 
Values are expressed as mean 士 S.D. (n=l 1). 
Means at the same row differ significantly at p<0.05 (a, b) and p<0.01 (c, d). 
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4.4.5 Effect of dietary magnesium on fecal neutral sterol output 
Concentration of neutral sterol in the feces of the hamsters at week 6 is shown in 
Table 4.5. There was no significant difference in total neutral sterol content in the 
feces of hamsters fed diets containing the three levels of magnesium. 
4.4.6 Effect of dietary magnesium on fecal acidic sterol output 
Concentration of fecal acidic sterol output is shown in Table 4.5. There was no 
significant difference in acidic sterol concentration in hamsters fed the three diets. 
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Table 4.5 Effects of three diets on fecal neutral and acidic sterol output in hamsters 
Mg 1.5g/kg Mg 1.0g/kg Mg 0.5g/kg 
(High) (Medium) (Adequate) 
Neutral Sterol (mg) 1.29 土 0.26 1.45 ±0.21 1.61 土 0.68 
Acidic Sterol (mg) 1.80 ±0.41 2.01 ± 0.67 1.81 ±1.49 
Cholesterol intake (mg) 10.57 ±0.60 10.62 ± 1.11 10,40 土 1.07 
Cholesterol retained (mg) 7.48 土 0.86 7.15 土 1.45 6.98 土 2.33 
Cholesterol 
7 0 . 6 3 土 4 . 8 8 6 7 . 0 1 士 9 . 6 0 6 6 . 4 1 ± 1 9 . 7 4 
retained/cholesterol intake (%) 
Values are expressed as mean 士 S.D. (n=ll). 
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4.6 Discussion 
The present study shows the similar body and organ weights among the three 
groups fed diets containing different levels of magnesium. No particular abnormalities 
were seen in these groups. In contrast, the hamsters in the magnesium deficient group 
appeared to be of malnutrition. Magnesium deficiency induced loss of appetite and 
thus body weight decreased to a level that could be fatal in hamsters. 
TG in Mg 1.5g/kg group significantly increased (p<0.05) compared with that in 
Mg 0.5g/kg group. The hepatic cholesterol, total fecal sterol output and the ratio of 
cholesterol retained to cholesterol intake were not significantly different among 
groups. It will be of interest to study the underlying mechanism by which dietary 
magnesium increased serum TG in the future. 
The present result was in disagreement with some previous studies. It was 
because the animal model used in the present study was hamster whereas previous 
studies used rabbit (Ouchi et al, 1990), rats (Olatunji & Soladoye, 2007; Rayssiguier 
et al, 1981; Takeda & Nakamura, 2008) or humans (Doyle et al, 1999; Witteman et al, 
1994). In one study, female Wistar rats were given ten folds to one — tenth fold of the 
normal magnesium requirement in diet, founding body weight of rats that received 
magnesium deficiency declined compared with the other groups (Takeda & Nakamura, 
2008). This result was similar to that observed in the present study. However, the 
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extent of the body weight drop in our study was much more severe. This may imply 
the tolerance of magnesium-lacking varies among species. Thus, the amount of 
magnesium added into diet needs adjustment for the further investigation. The amount 
of magnesium in a normal diet for hamster is about 0.5g/ kg diet which is similar to 
the amount of magnesium in adequate diet that used in the present study (National 
Research Council U.S.A, 1995). 
Theoretically, magnesium could have a similar effect as calcium because they 
can form fatty acid-Mg complex in the intestine and thus reduce the absorption of 
fatty acids (Drenick, 1961), and increase the excretion of cholesterol as bile acids 
from the liver (Vaskonen, 2003). Unexpectedly, the fecal output did not respond to the 
supplement of magnesium, which was different from the previous study on calcium 
supplementation. Amorphous calcium phosphate (ACP) formation elevated the fecal 
excretion and thus attenuates the retention of cholesterol in the body. The normal 
dietary content of calcium is much higher than that of magnesium. So, increasing 
magnesium intake may not exert such a great modification on fecal excretion as 
observed for dietary calcium (Rayssiguier & Gueux, 1986). 
Comparing the suggested mechanism (Rosanoff & Seelig, 2004) that magnesium 
supplementation affects the activation of HMGR and LCAT, this study only observed 
that serum TG significantly increased with dietary magnesium. In addition, 
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magnesium supplementation exerted no effect on blood lipid profile of male hamsters 
in the present study. The underlying mechanism remains unknown and further 




It has been well established that blood cholesterol and LDL-C are strongly 
correlated with the risk of heart disease. The present study demonstrated the dietary 
deficiency and inadequacy of calcium in both intact male and castrated hamsters did 
not have any effect on blood TC, HDL-C and TG levels. Hepatic cholesterol, and 
fecal neutral and acidic sterol output were not significantly different among Ca Def, 
Ca 8g/kg and Ca 2g/kg groups in male and castrated hamsters. However, the results 
were totally different when intact female and ovariectomized hamsters were used. 
The present result showed that in intact female hamsters, plasma TC (p<0.05), 
TG (p<0.01), nHDL-C (p<0.01) and nHDL-C/HDL-C ratio (p<0.01) of the Ca 8g/kg 
group was significantly lower than the Ca Def group. TC/HDL-C ratio of the Ca 
8g/kg group was significantly lower than the Ca 2g/kg group (p< 0.01) and Def group 
(p< 0.01). HDL-C of the Ca 8g/kg group was significantly higher than the other two 
groups (p< 0.01). In ovariectomized hamsters, plasma TC (p<0.05), nHDL-C 
(p<0.05), nHDL-C/HDL-C ratio (p<0.01) and TC/HDL-C ratio (p<0.01) of the Ca 
8g/kg were significantly lower than the Def group. HDL-C of the Ca 8g/kg group was 
significantly higher than the other groups (p< 0.05). TG in hamsters fed no calcium 
diets was not significantly different from that of the Ca 8g/kg. These data suggest that 
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dietary calcium deficiency in both intact female hamster and ovariectomized hamster 
produce a similar blood lipid profile. 
For hepatic cholesterol, intact female and ovariectomized hamsters with adequate 
calcium intake were significantly lower than the deficiency group (p< 0.01 and p< 
0.05 respectively). For the fecal total neutral sterol content, there was no significant 
difference in all groups of intact female hamsters whereas in ovariectomized hamsters, 
it was significantly higher in the Ca 8g/kg group than Ca Def group (p<0.05). The 
acidic sterol output of the Ca 8g/kg group of intact female and ovariectomized 
hamsters were significantly higher than the Def group (p<0.05). Thus, the cholesterol 
retained and the ratio of cholesterol retained relative to cholesterol intake of both 
female and ovariectomized hamsters were significantly reduced in the Ca 8g/kg group 
when compared with the Def group (p<0.05). Despite that there was no significant 
difference in cholesterol intake among all the groups. It can be concluded that female 
and ovariectomized hamsters exhibit the same pattern of alternation on hepatic 
cholesterol and acidic sterol output when the daily calcium becomes deficient. 
No change in the protein levels of hepatic protein of SREBP-2, HMGR, LDLR, 
LXR and CYP7A1 was found in both intact female and ovariectomized hamsters. On 
the other hand, the intestinal ACAT activity was significantly modulated. It is 
proposed that the decrease in blood TC and nHDL-C are mediated through the 
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inhibition of intestinal ACAT activity, leading to reduced cholesterol absorption. 
For hamsters with the supplementation of magnesium, TG (p<0.05) of the Mg 
1.5g/kg (High) group (p<0.05) was significantly increased compared with the Mg 
0.5g/kg (Adequate) group. However, none of the serum TC, HDL-C, nHDL-C, 
hepatic cholesterol, total fecal sterol output and the ratio of cholesterol retained to 
cholesterol intake showed significant change among all the groups. It appears that the 
supplementation of magnesium Mg 1.5g/kg in hamsters does not affect the blood lipid 
profile except for serum TG. 
The above findings contribute to a better understanding of the effect of dietary 
calcium deficiency on lipid and cholesterol metabolism in the intact and de-sexed 
hamsters. It remains unknown why dietary calcium has cholesterol-lowering activity 
in female and ovariectomized hamsters but it has little effect in male and castrated 
hamsters. Intact female and ovariectomized hamsters may be more sensitive to the 
change of the calcium in the diet than male. The future study will focus on 
investigation of the underlying mechanism by which dietary calcium affects serum 
lipoprotein profile only in female but not in male hamsters. 
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